MesotheliomaCenter's

Mesothelioma-Line

Curated Journal Articles on Mesothelioma

Category Archives: Tumor Debulking

Surgically removing as much of the tumor as possible. Also known as cytoreductive surgery in the pelvic/abdominal area.

Soluble Mesothelin-Related Peptides to Monitor Recurrence After Resection of Pleural Mesothelioma

Comments Off on Soluble Mesothelin-Related Peptides to Monitor Recurrence After Resection of Pleural Mesothelioma

Oncolytic Viral Therapy for Mesothelioma

Frontiers in Oncology 2017 August 24 [Link] Pease DF, Kratzke RA Abstract The limited effectiveness of conventional therapy for malignant pleural mesothelioma demands innovative approaches to this difficult disease. Even with aggressive multimodality treatment of surgery, radiation, and/or chemotherapy, the median survival is only 1-2 years depending on stage and histology. Oncolytic viral therapy has emerged […]

Comments Off on Oncolytic Viral Therapy for Mesothelioma

Remote Recurrence of Benign Multicystic Peritoneal Mesothelioma

Journal of Obstetrics 2017 July 18 [Epub ahead of print] [Link] Lee CE, Agrawal A Abstract BACKGROUND: Benign peritoneal cystic mesothelioma (BPCM) is a rare disease entity that arises from mesothelioma cells. We describe a rare case of BPCM recurrence 36 years after its initial presentation. CASE: A 62-year-old woman was referred to an outpatient […]

Comments Off on Remote Recurrence of Benign Multicystic Peritoneal Mesothelioma

The inhibition of FGF receptor 1 activity mediates sorafenib antiproliferative effects in human malignant pleural mesothelioma tumor-initiating cells

Stem cell research & therapy 2017 May 25 [Link] Pattarozzi A, Carra E, Favoni RE, Würth R, Marubbi D, Filiberti RA, Mutti L, Florio T, Barbieri F, Daga A Abstract BACKGROUND: Malignant pleural mesothelioma is an aggressive cancer, characterized by rapid progression and high mortality. Persistence of tumor-initiating cells (TICs, or cancer stem cells) after […]

Comments Off on The inhibition of FGF receptor 1 activity mediates sorafenib antiproliferative effects in human malignant pleural mesothelioma tumor-initiating cells

Diode-Pumped Laser for Lung-Sparing Surgical Treatment of Malignant Pleural Mesothelioma

The Annals of Thoracic Surgery 2017 June [Link] Bölükbas S1, Biancosino C2, Redwan B2, Eberlein M Abstract Surgical resection represents one of the essential cornerstones in multimodal treatment of malignant pleural mesothelioma. In cases of tumor infiltration of the lung, lung-scarifying procedures such as lobectomies or pneumonectomies might be necessary to achieve macroscopic complete resection. […]

Comments Off on Diode-Pumped Laser for Lung-Sparing Surgical Treatment of Malignant Pleural Mesothelioma

Physical function and health-related quality of life in patients undergoing surgical treatment for malignant pleural mesothelioma

Multinational Association of Supportive Care in Cancer 2017 March [Epub ahead of print] [Link] Tanaka T, Morishita S, Hashimoto M, Itani Y, Mabuchi S, Kodama N, Hasegawa S, Domen K Abstract Malignant pleural mesothelioma (MPM) is a rare cancer that affects the thin cell wall lining of internal organs and structures. Studies have shown that […]

Comments Off on Physical function and health-related quality of life in patients undergoing surgical treatment for malignant pleural mesothelioma

Impact of tumour thickness on survival after radical radiation and surgery in malignant pleural mesothelioma

The European Respiratory Journal 2017 March 15 [Print 2017] [Link] de Perrot M, Dong Z, Bradbury P, Patsios D, Keshavjee S, Leighl NB, Hope A, Feld R, Cho J Abstract Tumour thickness was assessed to determine if this parameter could refine patients’ selection for multimodality therapy in malignant pleural mesothelioma.We reviewed 65 consecutive treatment-naïve malignant […]

Comments Off on Impact of tumour thickness on survival after radical radiation and surgery in malignant pleural mesothelioma

HMGB1 targeting by ethyl pyruvate suppresses malignant phenotype of human mesothelioma

Oncotarget 2017 February 7 [Epub ahead of print] [Link] Pellegrini L, Xue J1 Larson D, Pastorino S, Jube S, Forest KH, Saad-Jube ZS, Napolitano A, Pagano I, Negi VS, Bianchi ME, Morris P, Pass HI, Gaudino G, Carbone M, Yang H Abstract Human malignant mesothelioma (MM) is an aggressive cancer linked to asbestos and erionite […]

Comments Off on HMGB1 targeting by ethyl pyruvate suppresses malignant phenotype of human mesothelioma

Peritoneal Deciduoid Mesothelioma

International Journal of Surgical Pathology 2017 January [Epub ahead of print] [Link] Dominiak N, Graybill W, Gunning W, Richardson MS, Spruill LS Abstract This report highlights a diagnostically challenging case of diffuse deciduoid mesothelioma occurring in the peritoneum of a 25-year-old woman, 8 months postpartum. Optimally debulked tumor consisted of sheets of polygonal cells arranged […]

Comments Off on Peritoneal Deciduoid Mesothelioma

Mentored experience of establishing a national peritoneal malignancy programme – Experience of first 50 operative cases

European Journal of Surgical Oncology 2016 November [Epub ahead of print] [Link] Chang KH, Kazanowski M, Staunton O, Cahill RA, Moran BJ, Shields C, Mulsow J Abstract BACKGROUND: Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) are considered standard of care for pseudomyxoma peritonei (PMP) and selected patients with colorectal peritoneal metastases (CPM) or peritoneal […]

Comments Off on Mentored experience of establishing a national peritoneal malignancy programme – Experience of first 50 operative cases